The latest news, views and analysis from the pharmaceutical industry’s frontline in the war on cancer. Updates on pharmaceutical and biotech oncology pipelines, regulatory decisions and market access news, and how healthcare systems needs to change to tackle one of the world’s biggest killers.
Alecensa part of Roche’s goal of becoming dominant player in NSCLC
Body unconvinced by clinical data for Venclyxto .
Leukaemia drug latest to move out of Cancer Drugs Fund
Proactive and included patients can help clinical trial retention.
Massachusetts-based company will test the waters for biotech sector
pharmaphorum media and Symplur, LLC launch Conference360 Report to help pharma and other stakeholders understand social media conversations around medical congresses
Roche faces competition against its blockbuster haematology drug